Cargando…

Diane-35 and Metformin Induce Autophagy and Apoptosis in Polycystic Ovary Syndrome Women with Early-Stage Endometrial Carcinoma

Objective: Women with polycystic ovary syndrome (PCOS) are at increased risk ofendometrial carcinoma (EC). Previous studies indicated that the combined therapy of Diane-35 and metformin significantly suppresses disease progression in PCOS patients with early EC; however, the mechanisms remain unclea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yanjun, Wang, Yang, Yao, Dan, Chen, Xing, Zhang, Feifei, Feng, Yi, Li, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775133/ https://www.ncbi.nlm.nih.gov/pubmed/35052471 http://dx.doi.org/10.3390/genes13010131

Ejemplares similares

Diane-35 and metformin therapy in rats with endometrial lesions induced by dihydrotestosterone exposure
por: Liu, Yanjun, et al.
Publicado: (2023)

Combination of Diane-35 and Metformin to Treat Early Endometrial Carcinoma in PCOS Women with Insulin Resistance
por: Li, Xin, et al.
Publicado: (2014)

Combined use of Diane-35 and metformin improves the ovulation in the PCOS rat model possibly via regulating glycolysis pathway
por: Zhang, Shun, et al.
Publicado: (2020)

Diane Lanster /
por: Wolfromm, Jean-Didier
Publicado: (1978)

Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine
por: Zhang, Feifei, et al.
Publicado: (2019)

Effect of Metformin on Serum Ferritin Level in Women with Polycystic Ovary Syndrome
por: Behradmanesh, S, et al.
Publicado: (2011)

Clinical outcome of various metformin treatments for women with polycystic ovary syndrome
por: Matsuzaki, Toshiya, et al.
Publicado: (2017)

Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome
por: Krysiak, Robert, et al.
Publicado: (2023)

Endometrial histology and predictable clinical factors for endometrial disease in women with polycystic ovary syndrome
por: Park, Joon Cheol, et al.
Publicado: (2011)

Metformin Therapy Decreases Hyperandrogenism and Ovarian Volume in Women with Polycystic Ovary Syndrome
por: Farimani Sanoee, Marzieh, et al.
Publicado: (2011)

Metformin increases pressure pain threshold in lean women with polycystic ovary syndrome
por: Kiałka, Marta, et al.
Publicado: (2016)

Thyroid Status During Pregnancy in Women With Polycystic Ovary Syndrome and the Effect of Metformin
por: Trouva, Anastasia, et al.
Publicado: (2022)

Reply to Dian et al
por: Thao, Le Thi Phuong, et al.
Publicado: (2018)

Polycystic ovary syndrome: early diagnosis and intervention are necessary for fertility preservation in young women with endometrial cancer under 35 years of age
por: Okamura, Yoshinori, et al.
Publicado: (2016)

La Diane de Fontainebleau 1686 /
por: Desmarets, Henri, 1661-1741
Publicado: (1987)

Women with polycystic ovary syndrome present with altered endometrial expression of stanniocalcin-1(†)
por: Khatun, Masuma, et al.
Publicado: (2020)

The Lifestyle Modifications and Endometrial Proteome Changes of Women With Polycystic Ovary Syndrome and Obesity
por: Abdulkhalikova, D., et al.
Publicado: (2022)

Metformin Treatment May Increase Omentin-1 Levels in Women With Polycystic Ovary Syndrome
por: Tan, Bee K., et al.
Publicado: (2010)

Effects of Metformin Treatment on Homocysteine Levels and Metabolic Parameters of Women With Polycystic Ovary Syndrome
por: Riahinejad, Soheila, et al.
Publicado: (2015)

Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome: A meta-analysis
por: Zeng, Xian-Ling, et al.
Publicado: (2016)

Impact of metformin on C-reactive protein levels in women with polycystic ovary syndrome: a meta-analysis
por: Chen, Yong, et al.
Publicado: (2017)

Lipidomic Biomarkers in Polycystic Ovary Syndrome and Endometrial Cancer
por: Shafiee, Mohamad Nasir, et al.
Publicado: (2020)

Wu li xue ci dian /
Publicado: (1988)

Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome
por: Xing, Chuan, et al.
Publicado: (2022)

Effects of metformin use in pregnant patients with polycystic ovary syndrome
por: Kumar, Pratap, et al.
Publicado: (2012)

Role of Metformin in Polycystic Ovary Syndrome (PCOS)-Related Infertility
por: Attia, Ghalia M, et al.
Publicado: (2023)

OR35-03 Uncovering Causative Mutations in Polycystic Ovary Syndrome
por: Srivastava, Jaya, et al.
Publicado: (2023)

Metformin improved health-related quality of life in ethnic Chinese women with polycystic ovary syndrome
por: Huang-TzOu, et al.
Publicado: (2016)

Ovulation induction by metformin among obese versus non-obese women with polycystic ovary syndrome
por: Al-Ruthia, Yazed Sulaiman, et al.
Publicado: (2017)

Association between Polymorphisms of OCT1 and Metabolic Response to Metformin in Women with Polycystic Ovary Syndrome
por: Chang, Hui Hua, et al.
Publicado: (2019)

The effects of empagliflozin vs metformin on endothelial microparticles in overweight/obese women with polycystic ovary syndrome
por: Javed, Zeeshan, et al.
Publicado: (2020)

Metformin Improves the Depression Symptoms of Women with Polycystic Ovary Syndrome in a Lifestyle Modification Program
por: AlHussain, Fatimah, et al.
Publicado: (2020)

Metformin induces lipid changes on sphingolipid species and oxidized lipids in polycystic ovary syndrome women
por: Pradas, Irene, et al.
Publicado: (2019)

Short-term combined treatment with exenatide and metformin for overweight/obese women with polycystic ovary syndrome
por: Ma, Rui-Lin, et al.
Publicado: (2021)

Myoinositol vs. Metformin in Women with Polycystic Ovary Syndrome: A Randomized Controlled Clinical Trial
por: Ravn, Pernille, et al.
Publicado: (2022)

Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis
por: Zeng, Huamin, et al.
Publicado: (2023)

Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome
por: Shan, Hongying, et al.
Publicado: (2022)

Comparison of exenatide alone or combined with metformin versus metformin in the treatment of polycystic ovaries: a systematic review and meta-analysis
por: Hu, Yan, et al.
Publicado: (2023)

Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome
por: Yang, Young-Mo, et al.
Publicado: (2015)

Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
por: Shahebrahimi, Karoon, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_04i0qafpef65832rjjv5g3v8j3